WGRX vs. NEUP
WGRX (Wellgistics Health, Inc) and NEUP (Neuphoria Therapeutics Inc) are both stocks. Both are in the Healthcare sector — WGRX in Pharmaceutical Retailers, NEUP in Biotechnology. Over the past year, WGRX returned -94.17% vs -27.93% for NEUP. At a 0.08 correlation, their price movements are largely independent.
Performance
WGRX vs. NEUP - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, WGRX achieves a -84.38% return, which is significantly lower than NEUP's 12.37% return.
WGRX
- 1D
- 0.65%
- 1M
- -24.55%
- YTD
- -84.38%
- 6M
- -85.42%
- 1Y
- -94.17%
- 3Y*
- —
- 5Y*
- —
- 10Y*
- —
NEUP
- 1D
- -1.80%
- 1M
- -20.44%
- YTD
- 12.37%
- 6M
- 15.65%
- 1Y
- -27.93%
- 3Y*
- —
- 5Y*
- —
- 10Y*
- —
WGRX vs. NEUP - Yearly Performance Comparison
| 2026 (YTD) | 2025 | |
|---|---|---|
WGRX Wellgistics Health, Inc | -84.38% | -90.82% |
NEUP Neuphoria Therapeutics Inc | 12.37% | -23.17% |
Correlation
The correlation between WGRX and NEUP is 0.07, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.08 |
Correlation (All Time) Calculated using the full available price history since Feb 21, 2025 | 0.08 |
Fundamentals
WGRX:
$326.42M
NEUP:
$23.59M
WGRX:
-$0.98
NEUP:
-$113.42
WGRX:
$14.03M
NEUP:
-$15.66M
WGRX:
-$10.16M
NEUP:
-$15.75M
WGRX:
-$53.11M
NEUP:
-$865.47M
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
WGRX vs. NEUP — Risk / Return Rank
WGRX
NEUP
WGRX vs. NEUP - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Wellgistics Health, Inc (WGRX) and Neuphoria Therapeutics Inc (NEUP). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| WGRX | NEUP | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -0.13 | ||
| Sortino ratioReturn per unit of downside risk | -1.23 | ||
| Omega ratioGain probability vs. loss probability | 0.95 | 1.13 | -0.19 |
| Calmar ratioReturn relative to maximum drawdown | -0.98 | -0.34 | -0.63 |
| Martin ratioReturn relative to average drawdown | -1.33 | -0.44 | -0.89 |
Loading charts...
Drawdowns
WGRX vs. NEUP - Drawdown Comparison
The maximum WGRX drawdown since its inception was -98.75%, which is greater than NEUP's maximum drawdown of -81.40%. Use the drawdown chart below to compare losses from any high point for WGRX and NEUP.
Loading charts...
Drawdown Indicators
| WGRX | NEUP | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -98.75% | -81.40% | -17.35% |
Max Drawdown (1Y)Largest decline over 1 year | -96.42% | -81.40% | -15.02% |
Current DrawdownCurrent decline from peak | -98.74% | -78.20% | -20.54% |
Average DrawdownAverage peak-to-trough decline | -76.05% | -44.60% | -31.45% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 70.97% | 63.87% | +7.10% |
Volatility
WGRX vs. NEUP - Volatility Comparison
Wellgistics Health, Inc (WGRX) has a higher volatility of 45.49% compared to Neuphoria Therapeutics Inc (NEUP) at 16.25%. This indicates that WGRX's price experiences larger fluctuations and is considered to be riskier than NEUP based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| WGRX | NEUP | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 45.49% | 16.25% | +29.24% |
Volatility (6M)Calculated over the trailing 6-month period | 118.84% | 32.32% | +86.52% |
Volatility (1Y)Calculated over the trailing 1-year period | 266.56% | 124.50% | +142.06% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 246.74% | 2,072.05% | -1,825.31% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 246.74% | 2,072.05% | -1,825.31% |
Dividends
WGRX vs. NEUP - Dividend Comparison
Neither WGRX nor NEUP has paid dividends to shareholders.
Financials
WGRX vs. NEUP - Financials Comparison
This section allows you to compare key financial metrics between Wellgistics Health, Inc and Neuphoria Therapeutics Inc. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
Frequently Asked Questions
WGRX and NEUP have a correlation of 0.07, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
WGRX has higher volatility (45.49%) compared to NEUP (16.25%). In terms of maximum drawdown, WGRX dropped -98.75% vs NEUP's -81.40%.
NEUP currently has the higher Sharpe Ratio (-0.23 vs -0.35), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for WGRX and NEUP
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer